Drug Research
X-Chem Acquires IntelliSyn and Sister Company, AviSyn, to Extend and Streamline Drug Discovery Service Range
X-Chem, Inc. (X-Chem), the industry-leading provider of DNA-Encoded Library (DEL)-based discovery services, has acquired IntelliSyn, a Montreal-based drug discovery services company and its US-based sister company, AviSyn. The transaction will enable the Company to offer a complete, seamless solution...
Drug Research
BioMed X Institute starts new research project in drug delivery in collaboration with Janssen
German independent research institute BioMed X announces its new research project with Janssen Research & Development, LLC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, which will strive to discover novel transport mechanisms in the human intestinal...
Drug Research
Enara and Boehringer Ingelheim sign oncology partnership
Enara and Boehringer Ingelheim have teamed up to discover and develop novel cancer immunotherapies against overlooked dark antigen targets. How could dark antigens improve the treatment of solid tumour cancers.
UK-based Enara Bio has entered into a collaboration with German-headquartered...
Drug Research
Nexelis acquires the GSK vaccines clinical bioanalytical laboratory located in Germany
Nexelis, a portfolio company of Ampersand Capital Partners, and a leading provider of advanced assay development and laboratory testing services in the infectious, oncologic, and metabolic diseases fields, has signed an asset purchase agreement with GSK to acquire its...
Drug Research
Lilly, Merus Ink Up-to-$1.6B Bispecific Antibody Partnership vs. Cancer
Eli Lilly’s oncology-focused Loxo Oncology at Lilly will partner with Merus to develop up to three CD3-engaging T-cell re-directing bispecific antibody therapies, through a research collaboration and exclusive licensing agreement that could generate up to $1.6 billion for the...
Drug Research
ConserV Bioscience and Lawrence Livermore National Laboratory to Collaborate on Development of Broad-spectrum Coronavirus Vaccine
ConserV Bioscience Limited (“ConserV”), a clinical-stage biotechnology company focused on developing vaccines that protect against endemic and emergent infectious diseases and Lawrence Livermore National Laboratory (“LLNL”) have agreed to collaborate on the development of a broad-spectrum coronavirus vaccine.
This collaboration...
Drug Research
Novartis and GSK announce collaboration to support scientific research into genetic diversity in Africa
Novartis and GSK announced the launch of a collaboration to support high-quality scientific research investigating the link between genetic diversity across different regions in Africa and its potential impact on response to drug therapeutics.
The Project Africa Genomic Research Approach...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.